GlaxoSmithKline (GSK)

Add to Watchlists Create an Alert
48.29 -0.31  -0.64% NYSE Jul 28, 10:25AM BATS Real time Currency in USD

GlaxoSmithKline Cash from Investing (TTM):

1.112B for June 30, 2014

View 4,000+ financial data types

View Full Chart

GlaxoSmithKline Cash from Investing (TTM) Chart

Export Data
Save Image

GlaxoSmithKline Historical Cash from Investing (TTM) Data

View and export this data going back to 1985. Start your YCharts Lite Membership
Export Data Date Range:
Viewing of   First  Previous First  Previous   Next  Last Next   Last
Data for this Date Range  
June 30, 2014 1.112B
March 31, 2014 729.75M
Dec. 31, 2013 819.61M
Sept. 30, 2013 -2.430B
June 30, 2013 -6.096B
March 31, 2013 -4.858B
Dec. 31, 2012 -4.169B
Sept. 30, 2012 -4.506B
June 30, 2012 -2.194B
March 31, 2012 -1.289B
Dec. 31, 2011 -179.51M
Sept. 30, 2011 -280.69M
June 30, 2011 1.150B
March 31, 2011 -1.044B
Dec. 31, 2010 -2.885B
Sept. 30, 2010 -2.884B
June 30, 2010 -5.657B
March 31, 2010 -5.811B
Dec. 31, 2009 -6.263B
Sept. 30, 2009 -6.820B
June 30, 2009 -3.687B
March 31, 2009 -2.569B
Dec. 31, 2008 -2.106B
Sept. 30, 2008 -3.432B
June 30, 2008 -2.333B
   
March 31, 2008 -4.594B
Dec. 31, 2007 -6.027B
Sept. 30, 2007 -4.562B
June 30, 2007 -6.309B
March 31, 2007 -4.431B
Dec. 31, 2006 -2.800B
Sept. 30, 2006 -3.807B
June 30, 2006 -3.773B
March 31, 2006 -3.426B
Dec. 31, 2005 -3.017B
Sept. 30, 2005 -1.044B
June 30, 2005 -995.56M
March 31, 2005 -1.306B
Dec. 31, 2004 -1.685B
Sept. 30, 2004 -2.087B
June 30, 2004 -1.735B
March 31, 2004 -1.571B
Dec. 31, 2003 -1.533B
Sept. 30, 2003 -1.597B
June 30, 2003 -1.588B
March 31, 2003 -1.694B
Dec. 31, 2002 -1.711B
Sept. 30, 2002 -2.324B
June 30, 2002 -1.396B
March 31, 2002 -2.205B

There is no data for the selected date range.

An error occurred. Please try again by refreshing your browser or contact us with details of your problem.

About Cash From Investing

An item on a company's cash flow statement. Lists aggregate change in cash position resulting from investing activities. Includes the company's cash inflows and outflows from investments in financial markets and the sale of capital assets.
Learn More

Get data for
Advertisement

GSK Cash from Investing (TTM) Benchmarks

Companies
AstraZeneca -6.302B
Pfizer 203.00M
Novartis 465.00M

GSK Cash from Investing (TTM) Range, Past 5 Years

Minimum -6.820B Sep 2009
Maximum 1.150B Jun 2011
Average -2.678B

GSK Cash from Investing (TTM) Excel Add-In Codes

  • Metric Code: cash_investing_ttm
  • Latest data point: =YCP("GSK", "cash_investing_ttm")
  • Last 5 data points: =YCS("GSK", "cash_investing_ttm", -4)

To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.

Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.

Advertisement

Already registered? Click here to sign in.

Access watchlists and custom data alerts.
Start your free account.

required
required
required
required
required
Get Started Now
document.write('');

{{root.upsell.info.feature_headline}}.
Upgrade to {{root.upsell.info.tier_name}}. Start your {{root.upsell.info.tier_name}} Membership

{{root.upsell.info.feature_description}}

{{root.upsell.info.is_upgrade ? "Upgrade Now" : "Start My Free Trial"}}

Already a {{root.upsell.info.tier_name}} Member? Sign in here.